Welcome to LookChem.com Sign In|Join Free
  • or
Quinazoline, 2-chloro-7-methoxy-4-methyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

58487-56-2

Post Buying Request

58487-56-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58487-56-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 58487-56-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,4,8 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 58487-56:
(7*5)+(6*8)+(5*4)+(4*8)+(3*7)+(2*5)+(1*6)=172
172 % 10 = 2
So 58487-56-2 is a valid CAS Registry Number.

58487-56-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-7-methoxy-4-methylquinazoline

1.2 Other means of identification

Product number -
Other names Quinazoline,2-chloro-7-methoxy-4-methyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58487-56-2 SDS

58487-56-2Downstream Products

58487-56-2Relevant academic research and scientific papers

QUINAZOLINE DERIVATIVES AS PDE10A ENZYME INHIBITORS

-

Page/Page column 48; 49; 50, (2013/04/24)

This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pr

QUINAZOLINES FOR PDK1 INHIBITION

-

, (2008/06/13)

The invention provides novel quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58487-56-2